Average Co-Inventor Count = 5.71
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Zymogenetics, Inc. (37 from 723 patents)
2. The University of Texas System (1 from 5,463 patents)
3. Bristol-Myers Squibb Compnay (3,685 patents)
4. Novo Nordisk A/s (1,778 patents)
37 patents:
1. 10227415 - Methods of producing a zcytor17 heterodimeric cytokine receptor
2. 9738700 - ZCYTOR17 heterodimeric cytokine receptor
3. 9605062 - Polynucleotides encoding ZCYTOR17 ligand antibodies
4. 9212213 - ZCYTOR17 heterodimeric cytokine receptor
5. 8778344 - Method of treating atopic dermatitis with antibody to zcytor17 ligand
6. 8647866 - ZCYTOR17 heterodimeric cytokine receptor polynucleotides
7. 8124378 - Murine zcytor17 ligand polynucleotides
8. 8013124 - Antibodies to human zcytor17 ligand
9. 7919595 - Antibodies to interferon-like protein Zcyto21(IL29)
10. 7833520 - Method of using interferon-like protein ZCYTO21(IL-29) to treat hepatitis B
11. 7799543 - Human tumor necrosis factor receptor polynucleotides
12. 7740834 - Murine zcytor17 ligand polypeptides
13. 7655223 - Method of using interferon-like protein ZCYTO21 (IL-29) to treat hepatitis C
14. 7608686 - Human tumor necrosis factor receptor
15. 7608452 - Polynucleotides encoding cytokine receptor zcytor19